5 Comments
User's avatar
R. Chad Swanson's avatar

Thanks. I appreciate the clear, compelling breakdown.

Expand full comment
Ryan McCormick, M.D.'s avatar

Excellent addition to the growing body of evidence. Very hard as a clinician to look the other way and deny this... plus it is a really motivating additional bit of counseling to review with patients considering Shingrix.

Expand full comment
Jenn Dowd, PhD's avatar

Yes it's such clever design and great to have additional benefits that motivate patients (dementia is something I assume people are really keen to prevent). Shingtix also seems to have a benefit *above and beyond* Zostavax-not suprising given its higher efficacy against shingles but still good to see in the data: https://www.nature.com/articles/s41591-024-03201-5

Expand full comment
Holly B.'s avatar

Interesting stuff! Thank you for breaking this down for us.

Expand full comment
Jenn Dowd, PhD's avatar

Thanks for reading and the kind words!

Expand full comment